Citation Impact
Citing Papers
CRACM1 Is a Plasma Membrane Protein Essential for Store-Operated Ca 2+ Entry
2006 StandoutScience
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
2012 StandoutNobel
miR-15 and miR-16 induce apoptosis by targeting BCL2
2005 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Simultaneous Activity of MRP1 and Pgp Is Correlated With In Vitro Resistance to Daunorubicin and With In Vivo Resistance in Adult Acute Myeloid Leukemia
1999
The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients
2003
Pancreatic cancer
2004 Standout
Regulation of cell death: the calcium–apoptosis link
2003 Standout
Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias
1995
Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer
2005
Cancer drug resistance: an evolving paradigm
2013 Standout
Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial
2006
Metabolism and action of amino acid analog anti-cancer agents
1990
An Expanded Set of Amino Acid Analogs for the Ribosomal Translation of Unnatural Peptides
2007 StandoutNobel
Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia
2002
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
1997 Standout
Significance of the levels of bone marrow lymphoid infiltrate in chronic lymphocytic leukemia patients with nodular partial remission
2002
Soft-Tissue Sarcomas in Adults
2005 Standout
Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas
1994
Signalling and Chromatin Fragmentation in Thymocyte Apoptosis
1994
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
The versatility and universality of calcium signalling
2000 Standout
Store-Operated Calcium Channels
2005 Standout
Induction of Apoptosis in HL-60 Human Promyelocytic Leukemia Cells by Adenosine A3Receptor Agonists
1996 StandoutNobel
Mitochondrial control of cell death
2000 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function
2006 StandoutNature
Regulation of cancer cell metabolism
2011 Standout
Four deaths and a funeral: from caspases to alternative mechanisms
2001 Standout
Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.
1996
Biology and management of relapsed acute myeloid leukaemia
2005
Infectious and immunosuppressive complications of purine analog therapy.
1995
Apoptosis driven by IP3-linked mitochondrial calcium signals
1999
CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia
1999
Structure of the human DNA ligast I gene
1992 StandoutNobel
Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
2000 Standout
Pancreatic Cancer
2010 Standout
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
Orai1 is an essential pore subunit of the CRAC channel
2006 StandoutNature
Mechanisms of apoptosis induction by nucleoside analogs
2003
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Inhibition of Mitochondrial Respiration
2003
Pancreatic cancer
2011 Standout
Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells
2005
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle.
1984 StandoutNobel
Gemcitabine and Docetaxel in Patients With Unresectable Leiomyosarcoma: Results of a Phase II Trial
2002
Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium
1996 StandoutNobel
Aberrant DNA repair and DNA replication due to an inherited enzymatic defect in human DNA ligase I
1994 StandoutNobel
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 StandoutScience
Expression of Apoptosis-Regulating Proteins in Chronic Lymphocytic Leukemia: Correlations With In Vitro and In Vivo Chemoresponses
1998
Cyclic guanosine monophosphate as a mediator of vasodilation.
1986 StandoutNobel
Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension.
1993
Bioactive Cardiac Substances: Potent Vasorelaxant Activity in Mammalian Atria
1983 Science
Metastatic Pancreatic Cancer 2008: Is the Glass Less Empty?
2008
Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism
2008
Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents
2003
Deregulation of the ubiquitin system and p53 proteolysis modify the apoptotic response in B-CLL lymphocytes
2000 StandoutNobel
Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia
2003
Resistance of leukemic cells to 2-chlorodeoxyadenosine is due to a lack of calcium-dependent cytochrome c release
2002
Proteasome Inhibitors Induce Apoptosis in Glucocorticoid-Resistant Chronic Lymphocytic Leukemic Lymphocytes
1998
Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues.
1984 StandoutNobel
Ischemic Cell Death in Brain Neurons
1999 Standout
Aberrant DNA repair and DNA replication due to an inherited enzymatic defect in human DNA ligase I.
1994 StandoutNobel
Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis
1999 Standout
STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane
2005 StandoutNature
Randomized Phase II Comparison of Dose-Intense Gemcitabine: Thirty-Minute Infusion and Fixed Dose Rate Infusion in Patients With Pancreatic Adenocarcinoma
2003
Enzymatic aminoacylation of tRNA with unnatural amino acids
2006 StandoutNobel
p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias
1995
Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung.
1986 StandoutNobel
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Deregulation of the ubiquitin system and p53 proteolysis modify the apoptotic response in B-CLL lymphocytes
2000 StandoutNobel
Repetitive Cycles of High-Dose Cytarabine Benefit Patients With Acute Myeloid Leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): Results from CALGB 8461
2004
Transient up-regulation of P2Y2nucleotide receptor mRNA expression is an immediate early gene response in activated thymocytes
1997 StandoutNobel
Induction of an apoptotic program in cell-free extracts by 2-chloro-2′-deoxyadenosine 5′-triphosphate and cytochrome c
1998
Analysis of the formation of AMP-DNA intermediate and the successive reaction by human DNA ligases I and II.
1992
Apoptosis: molecular mechanisms and implications for human disease
1995
Physiology of Microglia
2011 Standout
The Reactive Adventitia
2002
Comparison of idarubicin + ara-C–, fludarabine + ara-C–, and topotecan + ara-C–based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts
2001
Works of W. Plunkett being referenced
Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy.
1993
Combination of fludarabine and arabinosylcytosine for treatment of chronic lymphocytic leukemia: clinical efficacy and modulation of arabinosylcytosine pharmacology
1994
Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia.
1990
Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions
1996
Plasma and cerebrospinal fluid pharmacokinetics of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil following the repeated intravenous administration of high- and intermediate-dose 1-beta-D-arabinofuranosylcytosine.
1991
Dual mode of inhibition of purified DNA ligase I from human cells by 9-beta-D-arabinofuranosyl-2-fluoroadenine triphosphate.
1992
A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemia.
1995
Phase I clinical study of N-(phosphonacetyl)-L-aspartic acid (PALA).
1980
Arteriolar wall thickening in hypertensive rats unrelated to pressure or sympathoadrenergic influences.
1988
Induction of apoptotic cell death in chronic lymphocytic leukemia by 2- chloro-2'-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenine
1993
Increased arteriolar wall-to-lumen ratio in a normotensive vascular bed in coarctation hypertension
1985
Modulation of arabinosylnucleoside metabolism by arabinosylnucleotides in human leukemia cells.
1988
Evidence for a vascular sensitizing factor in plasma of saline-loaded dogs.
1982